Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
John Burnett
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Anatomy
Physiology
Phenomena
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
62
Heublein, Denise
59
Redfield, Margaret
38
Chen, Horng
37
Jougasaki, Michihisa
35
Cataliotti, Alessandro
24
Boerrigter, Guido
22
Schirger, John
22
Lerman, Amir
21
Costello-Boerrigter, Lisa
16
Rodeheffer, Richard
13
Lisy, Ondrej
13
Miller, Virginia
12
Luchner, Andreas
12
Martin, Fernando
12
Stevens, Tracy
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of John Burnett (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Boerrigter Guido; Costello-Boerrigter Lisa C; Burnett John C
Natriuretic peptides in the diagnosis and management of chronic heart failure.
Heart failure clinics 2009;5(4):501-14.
-
2009: McKie Paul M; Cataliotti Alessandro; Huntley Brenda K; Martin Fernando L; Olson Timothy M; Burnett John C
A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.
Journal of the American College of Cardiology 2009;54(11):1024-32.
-
2009: Miller Wayne L; Burnett John C; Hartman Karen A; Hodge David O; Giuliani Isabelle; Minard Florence; Larue Catherine; Jaffe Allan S
Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
Clinica chimica acta; international journal of clinical chemistry 2009;406(1-2):119-23.
-
2009: Chen H H; Martin F L; Gibbons R J; Schirger J A; Wright R S; Schears R M; Redfield M M; Simari R D; Lerman A; Cataliotti A; Burnett J C
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.
Heart (British Cardiac Society) 2009;95(16):1315-9.
-
2009: Pan Shuchong; Chen Horng H; Dickey Deborah M; Boerrigter Guido; Lee Candace; Kleppe Laurel S; Hall Jennifer L; Lerman Amir; Redfield Margaret M; Potter Lincoln R; Burnett John C; Simari Robert D
Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(27):11282-7.
-
2009: Costello-Boerrigter Lisa C; Burnett John C
A new role for the natriuretic peptides: metabolic regulators of the adipocyte.
Journal of the American College of Cardiology 2009;53(22):2078-9.
-
2009: Boerrigter Guido; Costello-Boerrigter Lisa C; Harty Gail J; Huntley Brenda K; Cataliotti Alessandro; Lapp Harald; Burnett John C
B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;296(6):R1744-50.
-
2009: Costello-Boerrigter Lisa C; Boerrigter Guido; Burnett John C
Pharmacology of vasopressin antagonists.
Heart failure reviews 2009;14(2):75-82.
-
2009: Chen Horng H; Cataliotti Alessandro; Schirger John A; Martin Fernando L; Harstad Lynn K; Burnett John C
Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure.
Journal of the American College of Cardiology 2009;53(15):1302-8.
-
2008: Cataliotti Alessandro; Chen Horng H; Schirger John A; Martin Fernando L; Boerrigter Guido; Costello-Boerrigter Lisa C; James Kenneth D; Polowy Karen; Miller Mark A; Malkar Navdeep B; Bailey Kent R; Burnett John C
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
Circulation 2008;118(17):1729-36.
-
2008: Martin Fernando L; Chen Horng H; Cataliotti Alessandro; Burnett John C
B-type natriuretic peptide: beyond a diagnostic.
Heart failure clinics 2008;4(4):449-54.
-
2008: Boerrigter Guido; Costello-Boerrigter Lisa C; Abraham William T; Sutton Martin G St John; Heublein Denise M; Kruger Kristin M; Hill Michael R S; McCullough Peter A; Burnett John C
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.
Journal of cardiac failure 2008;14(7):539-46.
-
2008: Lisy Ondrej; Huntley Brenda K; McCormick Daniel J; Kurlansky Paul A; Burnett John C
Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Journal of the American College of Cardiology 2008;52(1):60-8.
-
2008: Korinek Josef; Boerrigter Guido; Mohammed Selma F; Burnett John C
Insights into natriuretic peptides in heart failure: an update.
Current heart failure reports 2008;5(2):97-104.
-
2008: Buchner Stefan; Muscholl Michael; Debl Kurt; Hense Hans-Werner; Döring Angela; Stritzke Jan; Schunkert Heribert; Jougasaki Michihisa; Burnett John C; Riegger Günter A J; Luchner Andreas
Left atrial size by planimetry is superior to M-mode diameter: biochemical calibration by atrial and brain natriuretic peptide.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2008;21(4):380-5.
-
2008: Shapiro Brian P; Owan Theophilus E; Mohammed Selma; Kruger Martina; Linke Wolfgang A; Burnett John C; Redfield Margaret M
Mineralocorticoid signaling in transition to heart failure with normal ejection fraction.
Hypertension 2008;51(2):289-95.
-
2008: Mohammed Selma F; Korinek Josef; Chen Horng H; Burnett John C; Redfield Margaret M
Nesiritide in acute decompensated heart failure: current status and future perspectives.
Reviews in cardiovascular medicine 2008;9(3):151-8.
-
2008: Martin Fernando L; Chen Horng H; Cataliotti Alessandro; Burnett John C
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Reviews in cardiovascular medicine 2008;9(1):39-45.
-
2007: Costello-Boerrigter Lisa C; Boerrigter Guido; Burnett John C
V2 receptor antagonism with tolvaptan in heart failure.
Expert opinion on investigational drugs 2007;16(10):1639-47.
-
2007: Martin Fernando L; Supaporn Thanom; Chen Horng H; Sandberg Sharon M; Matsuda Yuzuru; Jougasaki Michihisa; Burnett John C
Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(4):R1580-5.
-
2007: Chen Horng H; Sundt Thoralf M; Cook David J; Heublein Denise M; Burnett John C
Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
Circulation 2007;116(11 Suppl):I134-8.
-
2007: Costello-Boerrigter Lisa C; Boerrigter Guido; Harty Gail J; Cataliotti Alessandro; Redfield Margaret M; Burnett John C
Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction.
Hypertension 2007;50(3):481-8.
-
2007: Frantz Robert P; Lowes Brian D; Grayburn Paul A; White Michel; Krause-Steinrauf Heidi; Krishnan Vaishali; Uyeda Lauren; Burnett John C;
Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Journal of cardiac failure 2007;13(6):437-44.
-
2007: Miller Wayne L; Hartman Karen A; Burritt Mary F; Grill Diane E; Rodeheffer Richard J; Burnett John C; Jaffe Allan S
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Circulation 2007;116(3):249-57.
-
2007: Lee Candace Y W; Burnett John C
Natriuretic peptides and therapeutic applications.
Heart failure reviews 2007;12(2):131-42.
-
2007: Miller Wayne L; Hartman Karen A; Burritt Mary F; Burnett John C; Jaffe Allan S
Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies.
Clinical cardiology 2007;30(5):245-50.
-
2007: Heublein Denise M; Huntley Brenda K; Boerrigter Guido; Cataliotti Alessandro; Sandberg Sharon M; Redfield Margaret M; Burnett John C
Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide.
Hypertension 2007;49(5):1114-9.
-
2007: Boerrigter Guido; Costello-Boerrigter Lisa C; Cataliotti Alessandro; Lapp Harald; Stasch Johannes-Peter; Burnett John C
Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
Hypertension 2007;49(5):1128-33.
-
2007: Lam Carolyn S P; Burnett John C; Costello-Boerrigter Lisa; Rodeheffer Richard J; Redfield Margaret M
Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Journal of the American College of Cardiology 2007;49(11):1193-202.
-
2007: Ammar Khawaja Afzal; Jacobsen Steven J; Mahoney Douglas W; Kors Jan A; Redfield Margaret M; Burnett John C; Rodeheffer Richard J
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community.
Circulation 2007;115(12):1563-70.
-
2007: Boerrigter Guido; Costello-Boerrigter Lisa C; Harty Gail J; Lapp Harald; Burnett John C
Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;292(2):R897-901.
-
2007: Ammar Khawaja Afzal; Makwana Ravindrakumar; Jacobsen Steven J; Kors Jan A; Burnett John C; Redfield Margaret M; Yawn Barbara P; Rodeheffer Richard J
Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiography.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2007;12(1):27-37.
-
2007: Cataliotti Alessandro; Chen Horng H; James Kenneth D; Burnett John C
Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular disease.
Trends in cardiovascular medicine 2007;17(1):10-4.
-
2007: Boerrigter Guido; Burnett John C
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Cardiovascular drug reviews 2007;25(1):30-45.
-
2006: Huntley Brenda K; Sandberg Sharon M; Noser Josh A; Cataliotti Alessandro; Redfield Margaret M; Matsuda Yuzuru; Burnett John C
BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.
Journal of cellular physiology 2006;209(3):943-9.
-
2006: Chen Horng H; Schirger John A; Cataliotti Alessandro; Burnett John C
Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(7):681-6.
-
2006: Chen Horng H; Huntley Brenda K; Schirger John A; Cataliotti Alessandro; Burnett John C
Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Journal of the American Society of Nephrology : JASN 2006;17(10):2742-7.
-
2006: Belluardo Paola; Cataliotti Alessandro; Bonaiuto Lorena; Giuffrè Eliana; Maugeri Egle; Noto Paola; Orlando Giovanna; Raspa Giuseppa; Piazza Brigida; Babuin Luciano; Chen Horng H; Martin Fernando L; McKie Paul M; Heublein Denise M; Burnett John C; Malatino Lorenzo S
Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy.
American journal of physiology. Heart and circulatory physiology 2006;291(4):H1529-35.
-
2006: Cataliotti Alessandro; Chen Horng H; Redfield Margaret M; Burnett John C
Natriuretic peptides as regulators of myocardial structure and function: pathophysiologic and therapeutic implications.
Heart failure clinics 2006;2(3):269-76.
-
2006: Bergeron Sébastien; Møller Jacob E; Bailey Kent R; Chen Horng H; Burnett John C; Pellikka Patricia A
Exertional changes in circulating cardiac natriuretic peptides in patients with suggested coronary artery disease.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2006;19(6):772-6.
-
2006: McKie Paul M; Rodeheffer Richard J; Cataliotti Alessandro; Martin Fernando L; Urban Lynn H; Mahoney Douglas W; Jacobsen Steven J; Redfield Margaret M; Burnett John C
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
Hypertension 2006;47(5):874-80.
-
2006: Ammar Khawaja Afzal; Makwana Ravindrakumar; Redfield Margaret M; Kors Jan A; Burnett John C; Rodeheffer Richard J
Unrecognized myocardial infarction: the association with cardiopulmonary symptoms and mortality is mediated via echocardiographic abnormalities of global dysfunction instead of regional dysfunction: the Olmsted County Heart Function Study.
American heart journal 2006;151(4):799-805.
-
2006: Detaint Delphine; Messika-Zeitoun David; Chen Horng H; Rossi Andrea; Avierinos Jean-François; Scott Christopher; Burnett John C; Enriquez-Sarano Maurice
Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation.
The American journal of cardiology 2006;97(7):1029-34.
-
2006: Costello-Boerrigter Lisa C; Smith William B; Boerrigter Guido; Ouyang John; Zimmer Christopher A; Orlandi Cesare; Burnett John C
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
American journal of physiology. Renal physiology 2006;290(2):F273-8.
-
2006: Costello-Boerrigter Lisa C; Boerrigter Guido; Redfield Margaret M; Rodeheffer Richard J; Urban Lynn H; Mahoney Douglas W; Jacobsen Steven J; Heublein Denise M; Burnett John C
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
Journal of the American College of Cardiology 2006;47(2):345-53.
-
2006: Lisy Ondrej; Burnett John C
New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing.
Circulation 2006;113(2):246-51.
-
2005: Hawkridge Adam M; Heublein Denise M; Bergen H Robert; Cataliotti Alessandro; Burnett John C; Muddiman David C
Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(48):17442-7.
-
2005: Miller Wayne L; Burnett John C; Hartman Karen A; Henle Michael P; Burritt Mary F; Jaffe Allan S
Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
The American journal of cardiology 2005;96(6):837-41.
-
2005: McKie Paul M; Burnett John C
B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities.
Mayo Clinic proceedings. Mayo Clinic 2005;80(8):1029-36.
-
2005: Cataliotti Alessandro; Schirger John A; Martin Fernando L; Chen Horng H; McKie Paul M; Boerrigter Guido; Costello-Boerrigter Lisa C; Harty Gail; Heublein Denise M; Sandberg Sharon M; James Kenneth D; Miller Mark A; Malkar Navdeep B; Polowy Karen; Burnett John C
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
Circulation 2005;112(6):836-40.
-
2005: Patel Jeetendra B; Valencik Maria L; Pritchett Allison M; Burnett John C; McDonald John A; Redfield Margaret M
Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
American journal of physiology. Heart and circulatory physiology 2005;289(2):H777-84.
-
2005: Detaint Delphine; Messika-Zeitoun David; Avierinos Jean-François; Scott Christopher; Chen Horng; Burnett John C; Enriquez-Sarano Maurice
B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
Circulation 2005;111(18):2391-7.
-
2005: Martin Fernando L; Stevens Tracy L; Cataliotti Alessandro; Schirger John A; Borgeson Daniel D; Redfield Margaret M; Luchner Andreas; Burnett John C
Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
Kidney international 2005;67(5):1723-30.
-
2005: Chen Horng H; Cataliotti Alessandro; Schirger John A; Martin Fernando L; Burnett John C
Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
American journal of physiology. Regulatory, integrative and comparative physiology 2005;288(5):R1093-7.
-
2005: Costello-Boerrigter Lisa C; Burnett John C
The prognostic value of N-terminal proB-type natriuretic peptide.
Nature clinical practice. Cardiovascular medicine 2005;2(4):194-201.
-
2005: Frantz Robert P; Olson Lyle J; Grill Diane; Moualla Soundos K; Nelson Susan M; Nobrega Thomas P; Hanna Richard D; Backes Richard J; Mookadam Farouk; Heublein Denise; Bailey Kent R; Burnett John C
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
American heart journal 2005;149(3):541-7.
-
2005: Munagala Vijaya K; Hart Chari Y T; Burnett John C; Meyer Donna M; Redfield Margaret M
Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure.
Circulation 2005;111(9):1128-35.
-
2005: Miller Wayne L; Hartman Karen A; Burritt Mary F; Borgeson Daniel D; Burnett John C; Jaffe Allan S
Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
Clinical chemistry 2005;51(3):569-77.
-
2005: Lisy Ondrej; Redfield Margaret M; Schirger John A; Burnett John C
Atrial BNP endocrine function during chronic unloading of the normal canine heart.
American journal of physiology. Regulatory, integrative and comparative physiology 2005;288(1):R158-62.
-
2005: James Kenneth D; Cataliotti Alessandro; Schirger John A; Plonka Shannon; Burnett John C
Congestive heart failure: pharmacological agents and the potential of B-type natriuretic Peptide.
Current medicinal chemistry 2005;12(12):1439-47.
-
2004: Munagala Vijaya K; Burnett John C; Redfield Margaret M
The natriuretic peptides in cardiovascular medicine.
Current problems in cardiology 2004;29(12):707-69.
-
2004: Pan Shuchong; Gulati Rajiv; Mueske Cheryl S; Witt Tyra A; Lerman Amir; Burnett John C; Simari Robert D
Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice.
American journal of physiology. Heart and circulatory physiology 2004;286(6):H2213-8.
-
2004: Chen Horng H; Redfield Margaret M; Nordstrom Lynda J; Horton Darlene P; Burnett John C
Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure.
Journal of cardiac failure 2004;10(2):115-9.
-
2004: Cataliotti Alessandro; Boerrigter Guido; Costello-Boerrigter Lisa C; Schirger John A; Tsuruda Toshihiro; Heublein Denise M; Chen Horng H; Malatino Lorenzo S; Burnett John C
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Circulation 2004;109(13):1680-5.
-
2004: Tsuruda Toshihiro; Costello-Boerrigter Lisa C; Burnett John C
Matrix metalloproteinases: pathways of induction by bioactive molecules.
Heart failure reviews 2004;9(1):53-61.
-
2004: Schirger John A; Chen Horng H; Jougasaki Michihisa; Lisy Ondrej; Boerrigter Guido; Cataliotti Alessandro; Burnett John C
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Circulation 2004;109(2):249-54.
-
2003: Boerrigter Guido; Burnett John C
Endothelin in neurohormonal activation in heart failure.
Coronary artery disease 2003;14(7):495-500.
-
2003: Jougasaki Michihisa; Leskinen Hanna; Larsen Amy M; Luchner Andreas; Cataliotti Alessandro; Tachibana Issei; Burnett John C
Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure.
Peptides 2003;24(6):889-92.
-
2003: Chen Horng H; Redfield Margaret M; Nordstrom Linda J; Cataliotti Alessandro; Burnett John C
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
American journal of physiology. Renal physiology 2003;284(5):F1115-9.
-
2003: Tsuruda Toshihiro; Jougasaki Michihisa; Boerrigter Guido; Costello-Boerrigter Lisa C; Cataliotti Alessandro; Lee Shang C; Salz-Gilman Lisa; Nordstrom Lynda J; McGregor Christopher G A; Burnett John C
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart.
Regulatory peptides 2003;112(1-3):161-6.
-
2003: Costello-Boerrigter Lisa C; Boerrigter Guido; Burnett John C
Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics.
The Medical clinics of North America 2003;87(2):475-91.
-
2003: Jougasaki Michihisa; Leskinen Hanna; Larsen Amy M; Cataliotti Alessandro; Chen Horng H; Burnett John C
Leukemia inhibitory factor is augmented in the heart in experimental heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(2):137-45.
-
2003: Boerrigter Guido; Costello-Boerrigter Lisa C; Cataliotti Alessandro; Tsuruda Toshihiro; Harty Gail J; Lapp Harald; Stasch Johannes-Peter; Burnett John C
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure.
Circulation 2003;107(5):686-9.
-
2003: Redfield Margaret M; Jacobsen Steven J; Burnett John C; Mahoney Douglas W; Bailey Kent R; Rodeheffer Richard J
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.
JAMA : the journal of the American Medical Association 2003;289(2):194-202.
-
2002: Tsuruda Toshihiro; Boerrigter Guido; Huntley Brenda K; Noser Josh A; Cataliotti Alessandro; Costello-Boerrigter Lisa C; Chen Horng H; Burnett John C
Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases.
Circulation research 2002;91(12):1127-34.
-
2002: Chen Horng H; Lainchbury John G; Burnett John C
Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide.
Journal of the American College of Cardiology 2002;40(6):1186-91.
-
2002: Redfield Margaret M; Rodeheffer Richard J; Jacobsen Steven J; Mahoney Douglas W; Bailey Kent R; Burnett John C
Plasma brain natriuretic peptide concentration: impact of age and gender.
Journal of the American College of Cardiology 2002;40(5):976-82.
-
2002: Cataliotti Alessandro; Giordano Mauro; De Pascale Emanuela; Giordano Gelsomina; Castellino Pietro; Jougasaki Michihisa; Costello Lisa C; Boerrigter Guido; Tsuruda Toshihiro; Belluardo Paola; Lee Shang-Chiun; Huntley Brenda; Sandberg Sharon; Malatino Lorenzo S; Burnett John C
CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome.
American journal of physiology. Renal physiology 2002;283(3):F464-72.
-
2002: Jougasaki Michihisa; Larsen Amy M; Cataliotti Alessandro; Christiansen David C; Burnett John C
Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells.
Peptides 2002;23(8):1441-7.
-
2002: Best Patricia J M; Burnett John C; Wilson Stephanie H; Holmes David R; Lerman Amir
Dendroaspis natriuretic peptide relaxes isolated human arteries and veins.
Cardiovascular research 2002;55(2):375-84.
-
2002: Lee Shang-Chiun; Stevens Tracy L; Sandberg Sharon M; Heublein Denise M; Nelson Susan M; Jougasaki Michihisa; Redfield Margaret M; Burnett John C
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Journal of cardiac failure 2002;8(3):149-54.
-
2002: Lainchbury John G; Lisy Ondrej; Burnett John C; Meyer Donna M; Redfield Margaret M
Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;282(4):R993-8.
-
2002: Chen Horng H; Lainchbury John G; Harty Gail J; Burnett John C
Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
Circulation 2002;105(8):999-1003.
-
2002: Tsuruda Toshihiro; Jougasaki Michihisa; Boerrigter Guido; Huntley Brenda K; Chen Horng H; D'Assoro Antonino B; Lee Shang C; Larsen Amy M; Cataliotti Alessandro; Burnett John C
Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor.
Circulation research 2002;90(2):128-34.
-
2002: Cataliotti Alessandro; Boerrigter Guido; Chen Horng H; Jougasaki Michihisa; Costello Lisa C; Tsuruda Toshihiro; Lee Shang-Chiun; Malatino Lorenzo S; Burnett John C
Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure.
Circulation 2002;105(5):639-44.
-
2002: Miller Wayne L; Bailey Kent R; Weston Susan A; Burnett John C; Rodeheffer Richard J
Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(1):63-72.
-
2001: Chen H H; Cataliotti A; Burnett J C
Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: insights from experimental heart failure.
Current hypertension reports 2001;3 Suppl 2():S15-21.
-
2001: Jougasaki M; Grantham J A; Redfield M M; Burnett J C
Regulation of cardiac adrenomedullin in heart failure.
Peptides 2001;22(11):1841-50.
-
2001: Cataliotti A; Malatino L S; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli S S; Heublein D M; Lainchbury J G; Leskinen H K; Bailey K R; Redfield M M; Burnett J C
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Mayo Clinic proceedings. Mayo Clinic 2001;76(11):1111-9.
-
2001: Hart C Y; Burnett J C; Redfield M M
Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice.
American journal of physiology. Heart and circulatory physiology 2001;281(5):H1938-45.
-
2001: Chen H H; Lainchbury J G; Matsuda Y; Harty G J; Burnett J C
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Hypertension 2001;38(2):187-91.
-
2001: Hart C Y; Meyer D M; Tazelaar H D; Grande J P; Burnett J C; Housmans P R; Redfield M M
Load versus humoral activation in the genesis of early hypertensive heart disease.
Circulation 2001;104(2):215-20.
-
2001: Hart C Y; Hahn E L; Meyer D M; Burnett J C; Redfield M M
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
American journal of physiology. Heart and circulatory physiology 2001;281(1):H146-54.
-
2001: Lisy O; Lainchbury J G; Leskinen H; Burnett J C
Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
Hypertension 2001;37(4):1089-94.
-
2001: Jougasaki M; Heublein D M; Sandberg S M; Burnett J C
Attenuated natriuretic response to adrenomedullin in experimental heart failure.
Journal of cardiac failure 2001;7(1):75-83.
-
2000: Luchner A; Borgeson D D; Grantham J A; Friedrich E; Riegger G A; Burnett J C; Redfield M M
Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dog.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(4):379-86.
-
2000: Chen H H; Grantham J A; Schirger J A; Jougasaki M; Redfield M M; Burnett J C
Subcutaneous administration of brain natriuretic peptide in experimental heart failure.
Journal of the American College of Cardiology 2000;36(5):1706-12.
-
2000: Harker-Murray A K; Tajik A J; Ishikura F; Meyer D; Burnett J C; Redfield M M
The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog.
Journal of cardiac failure 2000;6(3):233-42.
-
2000: Yamamoto K; Burnett J C; Bermudez E A; Jougasaki M; Bailey K R; Redfield M M
Clinical criteria and biochemical markers for the detection of systolic dysfunction.
Journal of cardiac failure 2000;6(3):194-200.
-
2000: Lainchbury J G; Meyer D M; Jougasaki M; Burnett J C; Redfield M M
Effects of adrenomedullin on load and myocardial performance in normal and heart-failure dogs.
American journal of physiology. Heart and circulatory physiology 2000;279(3):H1000-6.
-
2000: Burnett J C
Vasopeptidase inhibition.
Current opinion in nephrology and hypertension 2000;9(5):465-8.
-
2000: Luchner A; Jougasaki M; Friedrich E; Borgeson D D; Stevens T L; Redfield M M; Riegger G A; Burnett J C
Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(3):R974-9.
-
2000: Lisy O; Redfield M M; Jovanovic S; Jougasaki M; Jovanovic A; Leskinen H; Terzic A; Burnett J C
Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo.
Circulation 2000;102(3):338-43.
-
2000: Dzeja P P; Redfield M M; Burnett J C; Terzic A
Failing energetics in failing hearts.
Current cardiology reports 2000;2(3):212-7.
-
2000: Chen H H; Burnett J C
Natriuretic peptides in the pathophysiology of congestive heart failure.
Current cardiology reports 2000;2(3):198-205.
-
2000: Grantham J A; Schirger J A; Wennberg P W; Sandberg S; Heublein D M; Subkowski T; Burnett J C
Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
Circulation 2000;101(16):1976-81.
-
2000: Rossi A; Enriquez-Sarano M; Burnett J C; Lerman A; Abel M D; Seward J B
Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.
Journal of the American College of Cardiology 2000;35(5):1256-62.
-
2000: Schirger J A; Grantham J A; Kullo I J; Jougasaki M; Wennberg P W; Chen H H; Lisy O; Miller V; Simari R D; Burnett J C
Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition.
Journal of the American College of Cardiology 2000;35(3):796-801.
-
2000: Jougasaki M; Burnett J C
Adrenomedullin as a renal regulator peptide.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(3):293-5.
-
2000: Lainchbury J G; Burnett J C; Meyer D; Redfield M M
Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.
American journal of physiology. Heart and circulatory physiology 2000;278(1):H33-40.
-
2000: Jougasaki M; Tachibana I; Luchner A; Leskinen H; Redfield M M; Burnett J C
Augmented cardiac cardiotrophin-1 in experimental congestive heart failure.
Circulation 2000;101(1):14-7.
-
2000: Jougasaki M; Burnett J C
Adrenomedullin: potential in physiology and pathophysiology.
Life sciences 2000;66(10):855-72.
-
1999: Chen H H; Schirger J A; Chau W L; Jougasaki M; Lisy O; Redfield M M; Barclay P T; Burnett J C
Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
Circulation 1999;100(24):2443-8.
-
1999: Wennberg P W; Miller V M; Rabelink T; Burnett J C
Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism.
The American journal of physiology 1999;277(4 Pt 2):H1618-21.
-
1999: Chen H H; Burnett J C
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
Proceedings of the Association of American Physicians 1999;111(5):406-16.
-
1999: Lisy O; Burnett J C
Potential future therapies: natriuretic peptides.
Coronary artery disease 1999;10(6):389-94.
-
1999: Bracamonte M P; Burnett J C; Miller V M
Activation of soluble guanylate cyclase and potassium channels contribute to relaxations to nitric oxide in smooth muscle derived from canine femoral veins.
Journal of cardiovascular pharmacology 1999;34(3):407-13.
-
1999: Lisy O; Jougasaki M; Heublein D M; Schirger J A; Chen H H; Wennberg P W; Burnett J C
Renal actions of synthetic dendroaspis natriuretic peptide.
Kidney international 1999;56(2):502-8.
-
1999: Dzeja P P; Vitkevicius K T; Redfield M M; Burnett J C; Terzic A
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.
Circulation research 1999;84(10):1137-43.
-
1999: Burnett J C
Vasopeptidase inhibition: a new concept in blood pressure management.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1999;17(1):S37-43.
-
1999: Schirger J A; Heublein D M; Chen H H; Lisy O; Jougasaki M; Wennberg P W; Burnett J C
Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure.
Mayo Clinic proceedings. Mayo Clinic 1999;74(2):126-30.
-
1999: Jovanovic S; Grantham A J; Tarara J E; Burnett J C; Jovanovic A; Terzic A
Increased number of cardiomyocytes in cross-sections from tachycardia-induced cardiomyopathic hearts.
International journal of molecular medicine 1999;3(2):153-5.
-
1998: Hasdai D; Holmes D R; Higano S T; Burnett J C; Lerman A
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain.
Mayo Clinic proceedings. Mayo Clinic 1998;73(12):1133-40.
-
1998: Luchner A; Burnett J C; Jougasaki M; Hense H W; Riegger G A; Schunkert H
Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study.
Journal of the American College of Cardiology 1998;32(7):1839-44.
-
1998: Jougasaki M; Schirger J A; Simari R D; Burnett J C
Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin.
Hypertension 1998;32(5):917-22.
-
1998: Lisy O; Jougasaki M; Schirger J A; Chen H H; Barclay P T; Burnett J C
Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
The American journal of physiology 1998;275(3 Pt 2):F410-4.
-
1998: Borgeson D D; Stevens T L; Heublein D M; Matsuda Y; Burnett J C
Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Clinical science (London, England : 1979) 1998;95(2):195-202.
-
1998: Barber D A; Burnett J C; Fitzpatrick L A; Sieck G C; Miller V M
Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries.
Journal of cardiovascular pharmacology 1998;32(1):5-11.
-
1998: Lerman A; Burnett J C; Higano S T; McKinley L J; Holmes D R
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.
Circulation 1998;97(21):2123-8.
-
1998: Luchner A; Stevens T L; Borgeson D D; Redfield M; Wei C M; Porter J G; Burnett J C
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.
The American journal of physiology 1998;274(5 Pt 2):H1684-9.
-
1998: Borgeson D D; Grantham J A; Williamson E E; Luchner A; Redfield M M; Opgenorth T J; Burnett J C
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Hypertension 1998;31(3):766-70.
-
1998: Rasmussen T E; Jougasaki M; Supaporn T; Hallett J W; Brooks D P; Burnett J C
Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
The American journal of physiology 1998;274(1 Pt 2):R131-8.
-
1998: Chen H H; Burnett J C
C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
Journal of cardiovascular pharmacology 1998;32 Suppl 3():S22-8.
-
1998: Grantham J A; Schirger J A; Williamson E E; Heublein D M; Wennberg P W; Kirchengast M; Muenter K; Subkowski T; Burnett J C
Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S22-6.
-
1997: Barber D A; Park Y S; Burnett J C; Miller V M
Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries.
Journal of cardiovascular pharmacology 1997;30(5):695-701.
-
1997: Yamamoto K; Burnett J C; Redfield M M
Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.
The American journal of physiology 1997;273(5 Pt 2):H2406-14.
-
1997: Jougasaki M; Stevens T L; Borgeson D D; Luchner A; Redfield M M; Burnett J C
Adrenomedullin in experimental congestive heart failure: cardiorenal activation.
The American journal of physiology 1997;273(4 Pt 2):R1392-9.
-
1997: Chau W L; Burnett J C
Treatment of congestive heart failure in the elderly: emphasis on renal functional changes and impact of therapy.
Coronary artery disease 1997;8(8-9):505-9.
-
1997: Wei C M; Clavell A L; Burnett J C
Atrial and pulmonary endothelin mRNA is increased in a canine model of chronic low cardiac output.
The American journal of physiology 1997;273(2 Pt 2):R838-44.
-
1997: Brandt R R; Mattingly M T; Clavell A L; Barclay P L; Burnett J C
Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo.
Hypertension 1997;30(2 Pt 1):184-90.
-
1997: Wijdicks E F; Schievink W I; Burnett J C
Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage.
Journal of neurosurgery 1997;87(2):275-80.
-
1997: Grantham J A; Borgeson D D; Burnett J C
BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
The American journal of physiology 1997;272(4 Pt 2):R1077-83.
-
1997: Jougasaki M; Aarhus L L; Heublein D M; Sandberg S M; Burnett J C
Role of prostaglandins and renal nerves in the renal actions of adrenomedullin.
The American journal of physiology 1997;272(2 Pt 2):F260-6.
-
1997: Yamamoto K; Nishimura R A; Burnett J C; Redfield M M
Assessment of left ventricular end-diastolic pressure by Doppler echocardiography: contribution of duration of pulmonary venous versus mitral flow velocity curves at atrial contraction.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 1997;10(1):52-9.
-
1996: Yamamoto K; Burnett J C; Meyer L M; Sinclair L; Stevens T L; Redfield M M
Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model.
The American journal of physiology 1996;271(6 Pt 2):R1529-34.
-
1996: Yamamoto K; Burnett J C; Jougasaki M; Nishimura R A; Bailey K R; Saito Y; Nakao K; Redfield M M
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Hypertension 1996;28(6):988-94.
-
1996: Banks M; Wei C M; Kim C H; Burnett J C; Miller V M
Mechanism of relaxations to C-type natriuretic peptide in veins.
The American journal of physiology 1996;271(5 Pt 2):H1907-11.
-
1996: Supaporn T; Sandberg S M; Borgeson D D; Heublein D M; Luchner A; Wei C M; Dousa T P; Burnett J C
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
Kidney international 1996;50(5):1718-25.
-
1996: Wright R S; Wei C M; Kim C H; Kinoshita M; Matsuda Y; Aarhus L L; Burnett J C; Miller W L
C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
Journal of the American College of Cardiology 1996;28(4):1031-8.
-
1996: Luchner A; Stevens T L; Borgeson D D; Redfield M M; Bailey J E; Sandberg S M; Heublein D M; Burnett J C
Angiotensin II in the evolution of experimental heart failure.
Hypertension 1996;28(3):472-7.
-
1996: Stevens T L; Rasmussen T E; Wei C M; Kinoshita M; Matsuda Y; Burnett J C
Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
Journal of cardiac failure 1996;2(2):119-25.
-
1996: Supaporn T; Wennberg P W; Wei C M; Kinoshita M; Matsuda Y; Burnett J C
Role for the endogenous natriuretic peptide system in the control of basal coronary vascular tone in dogs.
Clinical science (London, England : 1979) 1996;90(5):357-62.
-
1996: Jougasaki M; Rodeheffer R J; Redfield M M; Yamamoto K; Wei C M; McKinley L J; Burnett J C
Cardiac secretion of adrenomedullin in human heart failure.
The Journal of clinical investigation 1996;97(10):2370-6.
-
1996: Flickinger A L; Burnett J C; Turner S T
Atrial natriuretic peptide and blood pressure.
Mayo Clinic proceedings. Mayo Clinic 1996;71(4):424.
-
1996: Clavell A L; Mattingly M T; Stevens T L; Nir A; Wright S; Aarhus L L; Heublein D M; Burnett J C
Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.
The Journal of clinical investigation 1996;97(5):1286-92.
-
1996: Cannan C R; Burnett J C; Lerman A
Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.
Circulation 1996;93(4):646-51.
-
1995: Cannan C R; Burnett J C; Brandt R R; Lerman A
Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Circulation 1995;92(11):3312-7.
-
1995: Lerman A; Holmes D R; Bell M R; Garratt K N; Nishimura R A; Burnett J C
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
Circulation 1995;92(9):2426-31.
-
1995: Flickinger A L; Burnett J C; Turner S T
Atrial natriuretic peptide and blood pressure in a population-based sample.
Mayo Clinic proceedings. Mayo Clinic 1995;70(10):932-8.
-
1995: Jougasaki M; Wei C M; McKinley L J; Burnett J C
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure.
Circulation 1995;92(3):286-9.
-
1995: Brandt R R; Heublein D M; Aarhus L L; Lewicki J A; Burnett J C
Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide.
The American journal of physiology 1995;269(1 Pt 2):H326-31.
-
1995: Evans M A; Burnett J C; Redfield M M
Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Journal of the American College of Cardiology 1995;25(6):1445-50.
-
1995: Textor S C; Burnett J C; Romero J C; Canzanello V J; Taler S J; Wiesner R; Porayko M; Krom R; Gores G; Hay E
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.
Kidney international 1995;47(5):1426-33.
-
1995: Jougasaki M; Wei C M; Aarhus L L; Heublein D M; Sandberg S M; Burnett J C
Renal localization and actions of adrenomedullin: a natriuretic peptide.
The American journal of physiology 1995;268(4 Pt 2):F657-63.
-
1995: Clavell A L; Stingo A J; Margulies K B; Brandt R R; Burnett J C
Role of endothelin receptor subtypes in the in vivo regulation of renal function.
The American journal of physiology 1995;268(3 Pt 2):F455-60.
-
1995: Stevens T L; Burnett J C; Kinoshita M; Matsuda Y; Redfield M M
A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
The Journal of clinical investigation 1995;95(3):1101-8.
-
1995: Brandt R R; Heublein D M; Mattingly M T; Pittelkow M R; Burnett J C
Presence and secretion of atrial natriuretic peptide from cultured human aortic endothelial cells.
The American journal of physiology 1995;268(2 Pt 2):H921-5.
-
1995: Jougasaki M; Wei C M; Heublein D M; Sandberg S M; Burnett J C
Immunohistochemical localization of adrenomedullin in canine heart and aorta.
Peptides 1995;16(4):773-5.
-
1994: Nir A; Beers K W; Clavell A L; Wei C M; Heublein D M; Dousa T P; Burnett J C
CNP is present in canine renal tubular cells and secreted by cultured opossum kidney cells.
The American journal of physiology 1994;267(6 Pt 2):R1653-7.
-
1994: Wei C M; Hu S; Miller V M; Burnett J C
Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells.
Biochemical and biophysical research communications 1994;205(1):765-71.
-
1994: Textor S C; Schwartz L; Canzanello V J; Wiesner R; Taler S J; Porayko M; Wilson D J; Krom R; Burnett J C; Romero J C
Resolution of posttransplant hypertension after liver transplantation despite impaired glomerular filtration.
Journal of the American Society of Nephrology : JASN 1994;5(5):1223-30.
-
1994: Mattingly M T; Brandt R R; Heublein D M; Wei C M; Nir A; Burnett J C
Presence of C-type natriuretic peptide in human kidney and urine.
Kidney international 1994;46(3):744-7.
-
1994: Chan D P; Clavell A; Keiser J; Burnett J C
Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(4):S43-9.
-
1994: Wei C M; Kim C H; Khraibi A A; Miller V M; Burnett J C
Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
Hypertension 1994;23(6 Pt 2):903-7.
-
1994: Stevens T L; Wei C M; Aahrus L L; Heublein D M; Kinoshita M; Matsuda Y; Burnett J C
Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.
Hypertension 1994;23(5):613-8.
-
1994: Nir A; Clavell A L; Heublein D; Aarhus L L; Burnett J C
Acute hypoxia and endogenous renal endothelin.
Journal of the American Society of Nephrology : JASN 1994;4(11):1920-4.
-
1994: Wei C M; Lerman A; Rodeheffer R J; McGregor C G; Brandt R R; Wright S; Heublein D M; Kao P C; Edwards W D; Burnett J C
Endothelin in human congestive heart failure.
Circulation 1994;89(4):1580-6.
-
1994: Brandt R R; Redfield M M; Aarhus L L; Lewicki J A; Burnett J C
Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure.
The American journal of physiology 1994;266(3 Pt 2):R936-43.
-
1994: Scherstén H; Aarnio P; Burnett J C; McGregor C G; Miller V M
Endothelin-1 in bronchoalveolar lavage during rejection of allotransplanted lungs.
Transplantation 1994;57(1):159-61.
-
1994: O'Murchu B; Miller V M; Perrella M A; Burnett J C
Increased production of nitric oxide in coronary arteries during congestive heart failure.
The Journal of clinical investigation 1994;93(1):165-71.
-
1994: Clavell A L; Burnett J C
Physiologic and pathophysiologic roles of endothelin in the kidney.
Current opinion in nephrology and hypertension 1994;3(1):66-72.
-
1993: Clavell A L; Stingo A J; Aarhus L L; Burnett J C
Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction.
The American journal of physiology 1993;265(6 Pt 2):R1416-22.
-
1993: Wei C M; Kim C H; Miller V M; Burnett J C
Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
The Journal of clinical investigation 1993;92(4):2048-52.
-
1993: Brandt R R; Wright R S; Redfield M M; Burnett J C
Atrial natriuretic peptide in heart failure.
Journal of the American College of Cardiology 1993;22(4 Suppl A):86A-92A.
-
1993: Wei C M; Kao P C; Lin J T; Heublein D M; Schaff H V; Burnett J C
Circulating beta-atrial natriuretic factor in congestive heart failure in humans.
Circulation 1993;88(3):1016-20.
-
1993: Wei C M; Heublein D M; Perrella M A; Lerman A; Rodeheffer R J; McGregor C G; Edwards W D; Schaff H V; Burnett J C
Natriuretic peptide system in human heart failure.
Circulation 1993;88(3):1004-9.
-
1993: Fett D L; Cavero P G; Burnett J C
Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Journal of the American Society of Nephrology : JASN 1993;4(2):162-7.
-
1993: Rodeheffer R J; Naruse M; Atkinson J B; Naruse K; Burnett J C; Merrill W H; Frist W H; Demura H; Inagami T
Molecular forms of atrial natriuretic factor in normal and failing human myocardium.
Circulation 1993;88(2):364-71.
-
1993: Perrella M A; Aarhus L L; Heublein D M; Lewicki J A; Burnett J C
Biologic role of atrial natriuretic factor clearance receptor in congestive heart failure.
The American journal of physiology 1993;265(1 Pt 2):H401-8.
-
1993: Stingo A J; Clavell A L; Aarhus L L; Burnett J C
Biological role for the endothelin-A receptor in aortic cross-clamping.
Hypertension 1993;22(1):62-6.
-
1993: Redfield M M; Aarhus L L; Wright R S; Burnett J C
Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction.
Circulation 1993;87(6):2016-22.
-
1993: Textor S C; Wiesner R; Wilson D J; Porayko M; Romero J C; Burnett J C; Gores G; Hay E; Dickson E R; Krom R A
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
Transplantation 1993;55(6):1332-9.
-
1993: Lerman A; Gibbons R J; Rodeheffer R J; Bailey K R; McKinley L J; Heublein D M; Burnett J C
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
Lancet 1993;341(8853):1105-9.
-
1993: Miller W L; Cavero P G; Aarhus L L; Heublein D M; Burnett J C
Endothelin-mediated cardiorenal hemodynamic and neuroendocrine effects are attenuated by nitroglycerin in vivo.
American journal of hypertension 1993;6(2):156-63.
-
1993: Clavell A L; Stingo A J; Wei C M; Heublein D M; Burnett J C
C-type natriuretic peptide: a selective cardiovascular peptide.
The American journal of physiology 1993;264(2 Pt 2):R290-5.
-
1993: Margulies K B; Burnett J C
Neutral endopeptidase 24.11: a modulator of natriuretic peptides.
Seminars in nephrology 1993;13(1):71-7.
-
1993: Wei C M; Aarhus L L; Miller V M; Burnett J C
Action of C-type natriuretic peptide in isolated canine arteries and veins.
The American journal of physiology 1993;264(1 Pt 2):H71-3.
-
1993: Khraibi A A; Heublein D M; Knox F G; Burnett J C
Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat.
Mayo Clinic proceedings. Mayo Clinic 1993;68(1):42-6.
-
1992: Khraibi A A; Granger J P; Haas J A; Burnett J C; Knox F G
Intrarenal pressures during direct inhibition of sodium transport.
The American journal of physiology 1992;263(6 Pt 2):R1182-6.
-
1992: Lerman A; Burnett J C
Intact and altered endothelium in regulation of vasomotion.
Circulation 1992;86(6 Suppl):III12-19.
-
1992: Lerman A; Kubo S H; Tschumperlin L K; Burnett J C
Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation.
Journal of the American College of Cardiology 1992;20(4):849-53.
-
1992: Stingo A J; Clavell A L; Heublein D M; Wei C M; Pittelkow M R; Burnett J C
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
The American journal of physiology 1992;263(4 Pt 2):H1318-21.
-
1992: Heublein D M; Clavell A L; Stingo A J; Lerman A; Wold L; Burnett J C
C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells.
Peptides 1992;13(5):1017-9.
-
1992: Underwood R D; Aarhus L L; Heublein D M; Burnett J C
Endothelin in thoracic inferior vena caval constriction model of heart failure.
The American journal of physiology 1992;263(3 Pt 2):H951-5.
-
1992: Rodeheffer R J; Lerman A; Heublein D M; Burnett J C
Increased plasma concentrations of endothelin in congestive heart failure in humans.
Mayo Clinic proceedings. Mayo Clinic 1992;67(8):719-24.
-
1992: Sandok E K; Lerman A; Stingo A J; Perrella M A; Gloviczki P; Burnett J C
Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor.
Journal of the American Society of Nephrology : JASN 1992;3(2):196-202.
-
1992: Perrella M A; Edell E S; Krowka M J; Cortese D A; Burnett J C
Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia.
The American journal of physiology 1992;263(1 Pt 2):R45-50.
-
1992: Miller V M; Burnett J C
Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries.
The American journal of physiology 1992;263(1 Pt 2):H103-8.
-
1992: Chan D P; Sandok E K; Aarhus L L; Heublein D M; Burnett J C
Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
American journal of hypertension 1992;5(6 Pt 1):354-60.
-
1992: Lerman A; Sandok E K; Hildebrand F L; Burnett J C
Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction.
Circulation 1992;85(5):1894-8.
-
1992: Perrella M A; Schwab T R; O'Murchu B; Redfield M M; Wei C M; Edwards B S; Burnett J C
Cardiac atrial natriuretic factor during evolution of congestive heart failure.
The American journal of physiology 1992;262(4 Pt 2):H1248-55.
-
1992: Stingo A J; Clavell A L; Aarhus L L; Burnett J C
Cardiovascular and renal actions of C-type natriuretic peptide.
The American journal of physiology 1992;262(1 Pt 2):H308-12.
-
1991: Margulies K B; Hildebrand F L; Heublein D M; Burnett J C
Radiocontrast increases plasma and urinary endothelin.
Journal of the American Society of Nephrology : JASN 1991;2(5):1041-5.
-
1991: Margulies K B; Perrella M A; McKinley L J; Burnett J C
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
The Journal of clinical investigation 1991;88(5):1636-42.
-
1991: Torres V E; Wilson D M; Burnett J C; Johnson C M; Offord K P
Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
Mayo Clinic proceedings. Mayo Clinic 1991;66(10):1010-7.
-
1991: Lerman A; Edwards B S; Hallett J W; Heublein D M; Sandberg S M; Burnett J C
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
The New England journal of medicine 1991;325(14):997-1001.
-
1991: Perrella M A; Hildebrand F L; Margulies K B; Burnett J C
Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function.
The American journal of physiology 1991;261(2 Pt 2):R323-8.
-
1991: Lerman A; Hildebrand F L; Aarhus L L; Burnett J C
Endothelin has biological actions at pathophysiological concentrations.
Circulation 1991;83(5):1808-14.
-
1991: Perrella M A; Margulies K B; Wei C M; Aarhus L L; Heublein D M; Burnett J C
Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.
The Journal of clinical investigation 1991;87(5):1649-55.
-
1991: Margulies K B; Heublein D M; Perrella M A; Burnett J C
ANF-mediated renal cGMP generation in congestive heart failure.
The American journal of physiology 1991;260(4 Pt 2):F562-8.
-
1991: Lerman A; Click R L; Narr B J; Wiesner R H; Krom R A; Textor S C; Burnett J C
Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation.
Transplantation 1991;51(3):646-50.
-
1990: Margulies K B; Hildebrand F L; Lerman A; Perrella M A; Burnett J C
Increased endothelin in experimental heart failure.
Circulation 1990;82(6):2226-30.
-
1990: Margulies K B; McKinley L J; Cavero P G; Burnett J C
Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure.
Kidney international 1990;38(6):1101-8.
-
1990: Edwards B S; Rodeheffer R J; Reeder G S; Burnett J C
Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation.
Journal of the American College of Cardiology 1990;16(7):1589-93.
-
1990: Winaver J; Burnett J C; Tyce G M; Dousa T P
ANP inhibits Na(+)-H+ antiport in proximal tubular brush border membrane: role of dopamine.
Kidney international 1990;38(6):1133-40.
-
1990: Lerman A; Hildebrand F L; Margulies K B; O'Murchu B; Perrella M A; Heublein D M; Schwab T R; Burnett J C
Endothelin: a new cardiovascular regulatory peptide.
Mayo Clinic proceedings. Mayo Clinic 1990;65(11):1441-55.
-
1990: Sanchez-Ferrer C F; Burnett J C; Lorenz R R; Vanhoutte P M
Possible modulation of release of atrial natriuretic factor by endothelium-derived relaxing factor.
The American journal of physiology 1990;259(3 Pt 2):H982-6.
-
1990: Cavero P G; Miller W L; Heublein D M; Margulies K B; Burnett J C
Endothelin in experimental congestive heart failure in the anesthetized dog.
The American journal of physiology 1990;259(2 Pt 2):F312-7.
-
1990: Loftus J P; Redfield M M; Burnett J C
Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics.
Kidney international 1990;38(2):227-31.
-
1990: Margulies K B; Cavero P G; Seymour A A; Delaney N G; Burnett J C
Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
Kidney international 1990;38(1):67-72.
-
1990: Margulies K B; Burnett J C
Atrial natriuretic factor modulates whole kidney tubuloglomerular feedback.
The American journal of physiology 1990;259(1 Pt 2):R97-101.
-
1990: Cavero P G; Margulies K B; Winaver J; Seymour A A; Delaney N G; Burnett J C
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
Circulation 1990;82(1):196-201.
-
1990: Khraibi A A; Heublein D M; Burnett J C; Knox F G
Renal interstitial hydrostatic pressure and ANF in exaggerated natriuresis of the SHR.
The American journal of physiology 1990;258(6 Pt 2):R1380-5.
-
1990: Khraibi A A; Heublein D M; Burnett J C; Knox F G
Dissociation of renal interstitial hydrostatic pressure and natriuresis of atrial natriuretic factor.
The American journal of physiology 1990;258(2 Pt 2):R481-6.
-
1990: Miller W L; Edwards B S; Zimmerman R S; Burnett J C
Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure.
Circulation research 1990;66(1):76-83.
-
1989: Lee M E; Miller W L; Edwards B S; Burnett J C
Role of endogenous atrial natriuretic factor in acute congestive heart failure.
The Journal of clinical investigation 1989;84(6):1962-6.
-
1989: Miller V M; Komori K; Burnett J C; Vanhoutte P M
Differential sensitivity to endothelin in canine arteries and veins.
The American journal of physiology 1989;257(4 Pt 2):H1127-31.
-
1989: Redfield M M; Edwards B S; Heublein D M; Burnett J C
Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure.
The American journal of physiology 1989;257(4 Pt 2):R917-23.
-
1989: Burnett J C; Osborn M J; Hammill S C; Heublein D M
The role of frequency of atrial contraction versus atrial pressure in atrial natriuretic peptide release.
The Journal of clinical endocrinology and metabolism 1989;69(4):881-4.
-
1989: Redfield M M; Edwards B S; McGoon M D; Heublein D M; Aarhus L L; Burnett J C
Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog.
Circulation 1989;80(3):651-7.
-
1989: Schini V B; Hendrickson H; Heublein D M; Burnett J C; Vanhoutte P M
Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells.
European journal of pharmacology 1989;165(2-3):333-4.
-
1989: Miller W L; Redfield M M; Burnett J C
Integrated cardiac, renal, and endocrine actions of endothelin.
The Journal of clinical investigation 1989;83(1):317-20.
-
1989: Gonzalez-Campoy J M; Kachelski J; Burnett J C; Romero J C; Granger J P; Knox F G
Proximal tubule response in aldosterone escape.
The American journal of physiology 1989;256(1 Pt 2):R86-90.
-
1988: Burnett J C
The atrial peptide system in cardiac disease.
American journal of hypertension 1988;1(4 Pt 2):410S-420S.
-
1988: Zimmerman R S; Ryan J; Edwards B S; Klee G; Zimmerman D; Scott N; Burnett J C
Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs.
The American journal of physiology 1988;255(1 Pt 2):R61-6.
-
1988: Showalter C J; Zimmerman R S; Schwab T R; Edwards B S; Opgenorth T J; Burnett J C
Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II.
The American journal of physiology 1988;254(3 Pt 2):R453-6.
-
1988: Edwards B S; Zimmerman R S; Schwab T R; Heublein D M; Burnett J C
Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.
Circulation research 1988;62(2):191-5.
-
1988: Edwards B S; Zimmerman R S; Schwab T R; Heublein D M; Burnett J C
Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhage.
The American journal of physiology 1988;254(1 Pt 2):R56-60.
-
1988: Edwards B S; Ackermann D M; Lee M E; Reeder G S; Wold L E; Burnett J C
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure.
The Journal of clinical investigation 1988;81(1):82-6.
-
1987: Burnett J C; Rubanyi G M; Edwards B S; Schwab T R; Zimmerman R S; Vanhoutte P M
Atrial natriuretic peptide decreases cardiac output independent of coronary vasoconstriction.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1987;186(3):313-8.
-
1987: Zimmerman R S; Schirger J A; Edwards B S; Schwab T R; Heublein D M; Burnett J C
Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
Circulation research 1987;61(1):63-9.
-
1987: Zimmerman R S; Edwards B S; Schwab T R; Heublein D M; Burnett J C
Atrial natriuretic peptide during mineralocorticoid escape in the human.
The Journal of clinical endocrinology and metabolism 1987;64(3):624-7.
-
1987: Zimmerman R S; Edwards B S; Schwab T R; Heublein D M; Burnett J C
Cardiorenal-endocrine dynamics during and following volume expansion.
The American journal of physiology 1987;252(2 Pt 2):R336-40.
-
1986: Edwards B S; Schwab T R; Zimmerman R S; Heublein D M; Jiang N S; Burnett J C
Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
Circulation research 1986;59(6):663-7.
-
1986: Schwab T R; Edwards B S; DeVries W C; Zimmerman R S; Burnett J C
Atrial endocrine function in humans with artificial hearts.
The New England journal of medicine 1986;315(22):1398-401.
-
1986: Schwab T R; Edwards B S; Heublein D M; Burnett J C
Role of atrial natriuretic peptide in volume-expansion natriuresis.
The American journal of physiology 1986;251(2 Pt 2):R310-3.
-
1986: Edwards B S; Ackermann D M; Schwab T R; Heublein D M; Edwards W D; Wold L E; Burnett J C
The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure.
Mayo Clinic proceedings. Mayo Clinic 1986;61(7):517-21.
Sign-in to see more
